4.5 Article

Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat-Biophysical Model and Predictions Based on Caco-2

期刊

PHARMACEUTICAL RESEARCH
卷 35, 期 1, 页码 -

出版社

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11095-017-2331-z

关键词

aqueous boundary layer permeability; Caco-2; dynamic range window (DRW); paracellular permeability; rat colon and small intestinal perfusion methods

资金

  1. European commission [DCI-ALA/19.09.01/10/21526/245-297/ALFA 111(2010)29]
  2. MINECO, Spain [Vitrubio- SAF2016-78756-P]
  3. Ministry of Education and Science of Spain [FPU 2012-00280]

向作者/读者索取更多资源

Purpose The effective rat intestinal permeability (P-eff) was deconvolved using a biophysical model based on parameterized paracellular, aqueous boundary layer, transcellular permeabilities, and the villus-fold surface area expansion factor. Methods Four types of rat intestinal perfusion data were considered: single-pass intestinal perfusion (SPIP) in the jejunum (n = 40), and colon (n = 15), closed-loop (Doluisio type) in the small intestine (n = 78), and colon (n = 74). Moreover, in vitro Caco-2 permeability values were used to predict rat in vivo values in the rat data studied. Results Comparable number of molecules permeate via paracellular water channels as by the lipoidal transcellular route in the SPIP method, although in the closed-loop method, the paracellular route appears dominant in the colon. The aqueous boundary layer thickness in the small intestine is comparable to that found in unstirred in vitro monolayer assays; it is thinner in the colon. The mucosal surface area in anaesthetized rats is 0.96-1.4 times the smooth cylinder calculated value in the colon, and it is 3.1-3.6 times in the small intestine. The paracellular permeability of the intestine appeared to be greater in rat than human, with the colon showing more leakiness (higher P-para) than the small intestine. Conclusion Based on log intrinsic permeability values, the correlations between the in vitro and in vivo models ranged from r(2) 0.82 to 0.92. The SPIP-Doluisio method comparison indicated identical log permeability selectivity trend with negligible bias.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

Quantitative assessment of the exposure-efficacy relationship of glucocerebrosidase using Markovian elements in Gaucher patients treated with enzyme replacement therapy

Elena Gras-Colomer, Victor Mangas-Sanjuan, Maria-Amparo Martinez-Gomez, Monica Climente-Marti, Matilde Merino-Sanjuan

Summary: A population pharmacokinetic model of enzyme activity in Gaucher-type 1 (GD1) patients after intravenous administration of enzyme replacement therapy (ERT) was developed, and an exposure-efficacy relationship for bone marrow infiltration was established. The findings of this study are of significant clinical relevance for the individualization of ERT in GD1 patients.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Article Chemistry, Multidisciplinary

An Innovative Formulation Based on Nanostructured Lipid Carriers for Imatinib Delivery: Pre-Formulation, Cellular Uptake and Cytotoxicity Studies

Evren Gundogdu, Emine-Selin Demir, Meliha Ekinci, Emre Ozgenc, Derya Ilem-Ozdemir, Zeynep Senyigit, Isabel Gonzalez-Alvarez, Marival Bermejo

Summary: Imatinib-loaded nanostructured lipid carrier system (F16-IMT) was successfully developed and characterized in this study. The F16-IMT formulation exhibited small particle size, stability, and efficient drug release. It also showed good cellular uptake and cytotoxicity against CRL-1739 cells. These findings suggest that F16-IMT has the potential to be an effective treatment for GIST.

NANOMATERIALS (2022)

Article Pharmacology & Pharmacy

Integration of In Silico, In Vitro and In Situ Tools for the Preformulation and Characterization of a Novel Cardio-Neuroprotective Compound during the Early Stages of Drug Development

Claudia Miranda, Alejandro Ruiz-Picazo, Paula Pomares, Isabel Gonzalez-Alvarez, Marival Bermejo, Marta Gonzalez-Alvarez, Alex Avdeef, Miguel-Angel Cabrera-Perez

Summary: The aim of this study was to characterize the biopharmaceutical properties of a new hybrid benzodiazepine-dihydropyridine derivative, JM-20. The results showed that JM-20 had higher solubility at acidic pH but low solubility overall. It also exhibited high permeability and absorption carrier-mediated transport mechanism. Based on the biopharmaceutical classification system, JM-20 was provisionally classified as class 2.

PHARMACEUTICS (2022)

Review Pharmacology & Pharmacy

Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis

Karine Rodriguez-Fernandez, Victor Mangas-Sanjuan, Matilde Merino-Sanjuan, Antonio Martorell-Calatayud, Almudena Mateu-Puchades, Monica Climente-Marti, Elena Gras-Colomer

Summary: The emergence of biological therapies has revolutionized the treatment of psoriasis. However, the complex pharmacokinetic properties of monoclonal antibodies (mAb) have posed challenges for dosage determination. This study reviewed population pharmacokinetic/pharmacodynamic (PK/PD) models of different types of mAb used in psoriasis treatment. The results showed that body weight and immunogenicity significantly influenced drug clearance. The lack of consensus on PK/PD relationships emphasizes the importance of therapeutic drug monitoring (TDM) in psoriasis treatment.

PHARMACEUTICS (2022)

Article Chemistry, Multidisciplinary

Radiolabeled Trastuzumab Solid Lipid Nanoparticles for Breast Cancer Cell: in Vitro and in Vivo Studies

Emre Ozgenc, Merve Karpuz, Ege Arzuk, Marta Gonzalez-Alvarez, Marival Bermejo Sanz, Evren Gundogdu, Isabel Gonzalez-Alvarez

Summary: This study prepared radiolabeled trastuzumab loaded solid lipid nanoparticles and investigated their biocompatibility, cellular uptake, and apoptosis induction capacity. The results showed that these nanoparticles exhibited favorable physicochemical properties and pharmacokinetic profiles.

ACS OMEGA (2022)

Article Pharmacology & Pharmacy

Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients

Isabel Gonzalez-alvarez, Barbara Sanchez-Dengra, Raquel Rodriguez-Galvez, Alejandro Ruiz-Picazo, Marta Gonzalez-alvarez, Alfredo Garcia-Arieta, Marival Bermejo

Summary: In the past, excipients were considered unimportant in the absorption process, but research has shown that this belief is not always true. This study investigated the reasons for a bioequivalence failure between two formulations of silodosin and found that the differences in excipients can indeed affect the drug's permeability through the gastrointestinal barrier.

PHARMACEUTICS (2022)

Article Pharmacology & Pharmacy

Establishment and Validation of a New Co-Culture for the Evaluation of the Permeability through the Blood-Brain Barrier in Patients with Glioblastoma

Barbara Sanchez-Dengra, Elena Garcia-Montoya, Isabel Gonzalez-Alvarez, Marival Bermejo, Marta Gonzalez-Alvarez

Summary: The aim of this study was to create and validate a new in vitro model capable of predicting the permeability across the blood-brain barrier in the presence of glioblastoma. The results showed that the co-culture model of MDCK and MDCK-MDR1 with U87-MG had high predictability in drug access to the central nervous system.

PHARMACEUTICS (2023)

Article Biotechnology & Applied Microbiology

Intranasal administration of molecular-gated mesoporous nanoparticles to increase ponatinib delivery to the brain

Barbara Sanchez-Dengra, Maria Alfonso, Isabel Gonzalez-Alvarez, Marival Bermejo, Marta Gonzalez-Alvarez, Ramon Martinez-Manez

Summary: The two types of nanoparticles loaded with ponatinib have been proven to be non-toxic to blood-brain barrier cells and have shown improved drug delivery to the brain compared to the free drug when administered intranasally. This research is significant for the treatment of brain cancer.

NANOMEDICINE (2023)

Meeting Abstract Gastroenterology & Hepatology

PHOSPHOLIPID PRODRUG DECREASES INFLAMMATORY MARKERS IN HUMAN INTESTINAL EXPLANTS: PROOF OF CONCEPT FOR AN INFLAMMATION-TARGETED DRUG DELIVERY STRATEGY FOR THE TREATMENT

Christopher Broxson, Milica Markovic, Arik Dahan, Shimon Ben-Shabat, Bikash Sahay, Ellen M. Zimmermann

GASTROENTEROLOGY (2022)

暂无数据